Component 2: Therapeutically Equivalent Substitutes Component 2: At the October 15, 2015 meeting: • Final discussion on the criteria to use in the o development of the evaluation of drugs to determine if they should be placed on the formulary as therapeutically equivalent substitutes. Introduction of a draft monograph to apply the o criteria in the evaluation tool. The monograph will be used to standardize the process and – ensure a transparent review. 8
Component 2: Therapeutically Equivalent Substitutes Component 2: • At the October 15, 2015 meeting: o Final discussion on the criteria to use in the development of the evaluation of drugs to determine if they should be placed on the formulary as therapeutically equivalent substitutes. o Introduction of a draft monograph to apply the criteria in the evaluation tool. – The monograph will be used to standardize the process and ensure a transparent review. 8
dfc-presentation-110515.docx